Mouse Anti-CNGA1 Recombinant Antibody (CBWJC-2851) (V2LY-1206-LY418)

Basic Information
Application | Note |
WB | 1:5,000 |
IF(ICC) | 1:10-1:100 |
IHC-P | 1:1,000 |
Formulations & Storage [For reference only, actual COA shall prevail!]
Target
Rhodopsin mediated signaling pathway Source: Reactome
Visual perception Source: ProtInc
A retinal dystrophy belonging to the group of pigmentary retinopathies. Retinitis pigmentosa is characterized by retinal pigment deposits visible on fundus examination and primary loss of rod photoreceptor cells followed by secondary loss of cone photoreceptors. Patients typically have night vision blindness and loss of midperipheral visual field. As their condition progresses, they lose their far peripheral visual field and eventually central vision as well.
Helical: 165-185
Extracellular: 186-198
Helical: 199-217
Cytoplasmic: 218-239
Helical: 240-259
Extracellular: 260-266
Helical: 267-288
Cytoplasmic: 289-299
Helical: 300-326
Extracellular: 327-369
Helical: 370-401
Cytoplasmic: 402-690
Submit a review and get a Coupon or an Amazon gift card. 20% off Coupon

Submit a review

Please try the standard protocols which include: protocols, troubleshooting and guide.
Enzyme-linked Immunosorbent Assay (ELISA)
Flow Cytometry
Immunofluorescence (IF)
Immunohistochemistry (IHC)
Immunoprecipitation (IP)
Western Blot (WB)
Enzyme-Linked Immunospot (ELISpot)
Proteogenomics
Other Protocols
Custom Antibody Labeling
We also offer labeled antibodies developed using our catalog antibody products and nonfluorescent conjugates (HRP, AP, Biotin, etc.) or fluorescent conjugates (Alexa Fluor, FITC, TRITC, Rhodamine, Texas Red, R-PE, APC, Qdot Probes, Pacific Dyes, etc.).
Online InquiryContact us
